PLIN5
Basic information
Region (hg38): 19:4522531-4535224
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PLIN5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 47 | 52 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 47 | 5 | 0 |
Variants in PLIN5
This is a list of pathogenic ClinVar variants found in the PLIN5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-4523533-A-G | not specified | Uncertain significance (Jun 16, 2023) | ||
19-4523542-C-G | not specified | Uncertain significance (Dec 28, 2023) | ||
19-4523565-G-A | not specified | Uncertain significance (Feb 23, 2023) | ||
19-4523583-G-A | not specified | Uncertain significance (Feb 06, 2023) | ||
19-4523605-C-T | not specified | Uncertain significance (May 11, 2022) | ||
19-4523611-C-A | not specified | Uncertain significance (Apr 22, 2022) | ||
19-4523631-C-T | not specified | Uncertain significance (May 31, 2024) | ||
19-4523704-G-A | not specified | Uncertain significance (Apr 26, 2024) | ||
19-4523716-C-A | not specified | Uncertain significance (Sep 13, 2023) | ||
19-4523719-C-T | not specified | Uncertain significance (Jun 24, 2022) | ||
19-4523757-G-T | not specified | Uncertain significance (Apr 12, 2023) | ||
19-4523811-G-A | not specified | Uncertain significance (Jan 19, 2024) | ||
19-4523854-C-A | not specified | Uncertain significance (Apr 08, 2024) | ||
19-4523869-C-T | not specified | Uncertain significance (Jun 07, 2022) | ||
19-4523874-C-T | not specified | Uncertain significance (Jan 23, 2024) | ||
19-4523878-G-A | not specified | Uncertain significance (Apr 11, 2023) | ||
19-4523880-C-T | not specified | Uncertain significance (Sep 27, 2022) | ||
19-4523898-G-A | not specified | Uncertain significance (Jul 20, 2021) | ||
19-4523919-C-T | not specified | Uncertain significance (Aug 02, 2021) | ||
19-4523930-G-C | not specified | Uncertain significance (Apr 06, 2024) | ||
19-4523961-C-T | not specified | Uncertain significance (Nov 22, 2021) | ||
19-4523976-T-C | not specified | Uncertain significance (Mar 18, 2024) | ||
19-4523992-C-G | not specified | Likely benign (Aug 02, 2021) | ||
19-4523992-C-T | not specified | Uncertain significance (Feb 27, 2023) | ||
19-4524003-C-T | not specified | Uncertain significance (Aug 22, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PLIN5 | protein_coding | protein_coding | ENST00000381848 | 7 | 12694 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.05e-11 | 0.0238 | 124766 | 0 | 42 | 124808 | 0.000168 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.520 | 301 | 277 | 1.09 | 0.0000190 | 2890 |
Missense in Polyphen | 110 | 101.82 | 1.0804 | 1048 | ||
Synonymous | -0.0335 | 126 | 126 | 1.00 | 0.00000907 | 979 |
Loss of Function | -0.366 | 16 | 14.5 | 1.10 | 6.75e-7 | 170 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00112 | 0.00111 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000557 | 0.0000556 |
Finnish | 0.0000464 | 0.0000464 |
European (Non-Finnish) | 0.000108 | 0.000106 |
Middle Eastern | 0.0000557 | 0.0000556 |
South Asian | 0.000200 | 0.000196 |
Other | 0.000175 | 0.000165 |
dbNSFP
Source:
- Function
- FUNCTION: Lipid droplet-associated protein that maintains the balance between lipogenesis and lipolysis and also regulates fatty acid oxidation in oxidative tissues. Recruits mitochondria to the surface of lipid droplets and is involved in lipid droplet homeostasis by regulating both the storage of fatty acids in the form of triglycerides and the release of fatty acids for mitochondrial fatty acid oxidation. In lipid droplet triacylglycerol hydrolysis, plays a role as a scaffolding protein for three major key lipolytic players: ABHD5, PNPLA2 and LIPE. Reduces the triacylglycerol hydrolase activity of PNPLA2 by recruiting and sequestering PNPLA2 to lipid droplets. Phosphorylation by PKA enables lipolysis probably by promoting release of ABHD5 from the perilipin scaffold and by facilitating interaction of ABHD5 with PNPLA2. Also increases lipolysis through interaction with LIPE and upon PKA-mediated phosphorylation of LIPE (By similarity). {ECO:0000250, ECO:0000269|PubMed:17234449}.;
- Pathway
- PPAR signaling pathway - Homo sapiens (human);Lipid storage and perilipins in skeletal muscle
(Consensus)
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.180
- ghis
- 0.432
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Plin5
- Phenotype
- adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- positive regulation of triglyceride biosynthetic process;positive regulation of lipid storage;positive regulation of sequestering of triglyceride;negative regulation of triglyceride catabolic process;lipid storage;negative regulation of fatty acid beta-oxidation;positive regulation of fatty acid beta-oxidation;lipid droplet organization;negative regulation of peroxisome proliferator activated receptor signaling pathway;mitochondrion localization;negative regulation of lipase activity;positive regulation of lipase activity;negative regulation of reactive oxygen species metabolic process
- Cellular component
- cytoplasm;mitochondrion;lipid droplet;cytosol
- Molecular function
- lipase binding;identical protein binding